FIELD: medicine.
SUBSTANCE: what is described is a composition for preparing a dosage form having prolonged action and containing drug preparations with radioprotective activity: Mexidol, Dimexidum, urea, methyluracil, sodium deoxyribonucleate, as well as a water-soluble polymer or a mixture of polymers specified in a group: sodium alginate, pectin, chitosan salt, water, and a substance or a mixture of substances having antiradical properties, and specified in a group consisting of sea buckthorn, bilberry, glycerol, polyethylene glycol, with the following ratio of ingredients, wt %: thickening polymer 1.0-8.0; pharmacological agent in a therapeutically effective amount; substances having antiradical properties 0.5-6.0; distilled water - the rest.
EFFECT: higher degree of intact tissue protection against radiation damages.
8 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING THERAPEUTIC HYDROGEL | 2014 |
|
RU2563232C1 |
METHOD OF OBTAINING MEDICINAL COMPOSITION FOR ITS APPLICATION ON TEXTILE MATERIAL | 2009 |
|
RU2400250C1 |
METHOD FOR PRODUCING THERAPEUTIC TISSUE | 2014 |
|
RU2539381C1 |
METHOD FOR PRODUCING A THERAPEUTIC HYDROGEL | 2017 |
|
RU2653411C1 |
METHOD OF COMPOSITION CREATION FOR MEDICAL PREPARATION DELIVERY IN ORGANISM CAVITY AT DISEASES | 2007 |
|
RU2352359C1 |
PHARMACEUTIC COMPOSITION FOR APPLICATION IN ONCOLOGY | 2014 |
|
RU2560702C1 |
METHOD FOR PRODUCING ANTIMICROBIAL GEL | 2020 |
|
RU2746709C1 |
COMPOSITION FOR MAKING DOSAGE FORM WITH PROLONGED EFFECT AND METHOD OF MAKING SAID FORM | 2007 |
|
RU2363451C2 |
WOUND TISSUE | 2012 |
|
RU2483755C1 |
WOUND HEALING AGENT | 2009 |
|
RU2403014C1 |
Authors
Dates
2014-06-20—Published
2012-10-23—Filed